Home » Newsletters » BioWorld

BioWorld

March 24, 1993

View Archived Issues

APPOINTMENTS AND ADVANCEMENTS

FDA WANTS MORE DATA ON PROSORBA

ATHENA TO MARKET SANDOZ'S PARKINSON'S DRUG

BIOCHEM PHARMA TO START TRIALS

CYANAMID, HOUGHTEN TO COLLABORATE ON SCREENING

BIORELEASE FILES FOR UNIT OFFERING

BTG GETS PATENT FOR SOD GENE

CADUS LICENSES DRUG SCREENING TECHNOLOGY

SYNERGEN PLANS ANOTHER ANTRIL TRIAL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.